Susan Benton is Director at Ocuphire Pharma, Inc. (OCUP). They have made 1 open-market trade across 1 company since 2021, most recently 2026-04-20.
CIK 0001373649
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $91K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OCUP | BUY | 2021-09-02 | 2021-09-03 | $4.57 | $91K | +15.8% | +10.9% | -16.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.